These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 2324156

  • 1. Antitumor effects of a new interleukin-2 slow delivery system on methylcholanthrene-induced fibrosarcoma in mice.
    Fujiwara T, Sakagami K, Orita K.
    J Cancer Res Clin Oncol; 1990; 116(2):141-8. PubMed ID: 2324156
    [Abstract] [Full Text] [Related]

  • 2. Augmentation of antitumor effect on syngeneic murine solid tumors by an interleukin 2 slow delivery system, the IL-2 mini-pellet.
    Fujiwara T, Sakagami K, Matsuoka J, Shiozaki S, Fujioka K, Takada Y, Uchida S, Onoda T, Orita K.
    Biotherapy; 1991; 3(3):203-9. PubMed ID: 1854589
    [Abstract] [Full Text] [Related]

  • 3. Prolongation of serum half-life of interleukin 2 and augmentation of lymphokine-activated killer cell activity by pepstatin in mice.
    Ohnishi H, Lin KM, Chu TM.
    Cancer Res; 1990 Feb 15; 50(4):1107-12. PubMed ID: 2297759
    [Abstract] [Full Text] [Related]

  • 4. [Studies on lymphokine-activated killer (LAK) cell: accumulation in tumor tissue and the therapeutic effects of adoptive immunotherapy].
    Wakizaka Y.
    Hokkaido Igaku Zasshi; 1992 Jul 15; 67(4):475-87. PubMed ID: 1330859
    [Abstract] [Full Text] [Related]

  • 5. Lymphocyte migration to tumors after hyperthermia and immunotherapy.
    Midis GP, Fabian DF, Lefor AT.
    J Surg Res; 1992 May 15; 52(5):530-6. PubMed ID: 1619922
    [Abstract] [Full Text] [Related]

  • 6. Effects of cancer immunotherapy with indomethacin and interleukin-2 on murine hemopoietic stem cells.
    Saarloos MN, Khoo NK, Lala PK.
    Cancer Res; 1992 Dec 01; 52(23):6452-62. PubMed ID: 1423293
    [Abstract] [Full Text] [Related]

  • 7. Induction of endogenous lymphokine-activated killer activity by combined administration of lentinan and interleukin 2.
    Suzuki M, Higuchi S, Taki Y, Taki S, Miwa K, Hamuro J.
    Int J Immunopharmacol; 1990 Dec 01; 12(6):613-23. PubMed ID: 2272726
    [Abstract] [Full Text] [Related]

  • 8. Marked reduction of subcutaneous tumor growth by intraperitoneal administration of recombinant human interleukin 2 with a cell accumulator, proteose-peptone, in mice.
    Tanida S, Uchida H, Taniguchi K, Nomoto K.
    Cancer Res; 1989 Jan 15; 49(2):284-8. PubMed ID: 2783379
    [Abstract] [Full Text] [Related]

  • 9. Combined effects of intraperitoneal administration of recombinant interleukin-2 and streptococcal preparation OK-432 in murine tumors.
    Fujioka T, Ishikura K, Tanji S, Okamoto T, Koike H, Aoki H, Ohhori T, Kubo T.
    Int J Immunopharmacol; 1990 Jan 15; 12(4):419-26. PubMed ID: 2391188
    [Abstract] [Full Text] [Related]

  • 10. In vivo boosting of lung natural killer and lymphokine-activated killer cell activity by interleukin-2: comparison of systemic, intrapleural and inhalation routes.
    Flexman JP, Manning LS, Robinson BW.
    Clin Exp Immunol; 1990 Oct 15; 82(1):151-6. PubMed ID: 2208789
    [Abstract] [Full Text] [Related]

  • 11. Application of an interleukin 2 slow delivery system to the immunotherapy of established murine colon 26 adenocarcinoma liver metastases.
    Fujiwara T, Sakagami K, Matsuoka J, Shiozaki S, Uchida S, Fujioka K, Takada Y, Onoda T, Orita K.
    Cancer Res; 1990 Nov 01; 50(21):7003-7. PubMed ID: 2208166
    [Abstract] [Full Text] [Related]

  • 12. Use of N-acetyl cysteine to increase intracellular glutathione during the induction of antitumor responses by IL-2.
    Yim CY, Hibbs JB, McGregor JR, Galinsky RE, Samlowski WE.
    J Immunol; 1994 Jun 15; 152(12):5796-805. PubMed ID: 8207209
    [Abstract] [Full Text] [Related]

  • 13. Enhanced activity against syngeneic murine tumors by intrasplenic injection of recombinant interleukin-2 (IL-2) and interleukin-1 (IL-1).
    Nakajima I, Ozaki M, Jinnai H, Shilayama Y, Hirohata T, Okuno K, Yasutomi M.
    Cancer Biother; 1993 Jun 15; 8(4):319-26. PubMed ID: 7804373
    [Abstract] [Full Text] [Related]

  • 14. Augmented accumulation of transferred lymphokine-activated killer (LAK) cells at murine tumor sites through production of LAK-attractant facilitated by chemotherapy.
    Hosokawa M, Wakizaka Y, Kuramitsu Y, Micallef M, Togashi Y, Kobayashi H.
    Tohoku J Exp Med; 1992 Oct 15; 168(2):413-6. PubMed ID: 1306328
    [Abstract] [Full Text] [Related]

  • 15. Adoptive immunotherapy using lymphokine-activated killer cells and recombinant interleukin-2 in preventing and treating spontaneous pulmonary metastases of syngeneic Dunning rat prostate tumor.
    Tjota A, Zhang YQ, Piedmonte MR, Lee CL.
    J Urol; 1991 Jul 15; 146(1):177-83. PubMed ID: 2056587
    [Abstract] [Full Text] [Related]

  • 16. Effect of Krestin (PSK) on the induction of IL-2 activated killer cells.
    Sakamaki S, Kohgo Y, Nojiri S, Kanisawa Y, Ito Y, Takahashi M, Ueno Y, Hirayama Y, Niitsu Y.
    Jpn J Clin Oncol; 1992 Apr 15; 22(2):79-83. PubMed ID: 1619782
    [Abstract] [Full Text] [Related]

  • 17. Enhanced survival of IFN-alpha augmented IL-2 therapy of pulmonary metastases: efficacy comparable to interleukin-2 and lymphokine activated killer cells.
    Kim B, Warnaka P.
    J Surg Res; 1991 Jan 15; 50(1):40-6. PubMed ID: 1987429
    [Abstract] [Full Text] [Related]

  • 18. Postoperative administration of interleukin-12 significantly enhances the anti-tumor immune response of MBT-2 bladder cancer bearing mice.
    Tzai TS, Shiau AL, Wu CL, Tsai YS.
    Proc Natl Sci Counc Repub China B; 2000 Apr 15; 24(2):56-62. PubMed ID: 10809081
    [Abstract] [Full Text] [Related]

  • 19. Augmentation of murine lymphokine-activated killer cell cytotoxicity by beta-cyclodextrin-benzaldehyde.
    Kuroki Y, Ochiai H, Kurokawa M, Niwayama S, Kishimoto C, Tazawa K, Fujimaki M.
    J Cancer Res Clin Oncol; 1991 Apr 15; 117(2):109-14. PubMed ID: 2007609
    [Abstract] [Full Text] [Related]

  • 20. IL-4-induced lymphokine-activated killer cells. Lytic activity is mediated by phenotypically distinct natural killer-like and T cell-like large granular lymphocytes.
    Peace DJ, Kern DE, Schultz KR, Greenberg PD, Cheever MA.
    J Immunol; 1988 May 15; 140(10):3679-85. PubMed ID: 2896213
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.